Apolipoprotein e genotype modifies the association between midlife lung function and cognitive function in old age

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 5, 2009, Pages 433-441

  Giltay, Erik J ^a   Nissinen, Aulikki ^c   Giampaoli, Simona ^d   Kromhout, Daan ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Apolipoprotein E 4; Cognitive function; Dementia; Lung function; Prospective cohort study

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ARTICLE; CLINICAL DEMENTIA RATING SCORE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; EXPIRATORY FLOW; FEMALE; FINLAND; FOLLOW UP; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; ITALY; LUNG FUNCTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NETHERLANDS; NEUROLOGIC EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTERACTION; RATING SCALE; RESPIRATORY FUNCTION; SCORING SYSTEM; SENESCENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; COGNITION; COGNITION DISORDERS; COHORT STUDIES; DEMENTIA; EUROPE; FOLLOW-UP STUDIES; FORCED EXPIRATORY FLOW RATES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; VITAL CAPACITY;

EID: 70449514634     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000255600     Document Type: Article

References (38)

1. Cummings JL: Alzheimer's disease. N Engl J Med 2004; 351: 56-67.
2. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I: Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002; 156: 445-453.
3. de la Torre JC: Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184-190.
4. Incalzi RA, Gemma A, Marra C, Capparella O, Fuso L, Carbonin P: Verbal memory impairment in COPD: Its mechanisms and clinical relevance. Chest 1997; 112: 1506-1513.
5. Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson-LOHR V: Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160: 50-56.
6. Decary A, Rouleau I, Montplaisir J: Cognitive deficits associated with sleep apnea syndrome: A proposed neuropsychological test battery. Sleep 2000; 23: 369-381.
7. Liesker JJ, Postma DS, Beukema RJ, ten Hacken NH, van der MT, Riemersma RA, van Zomeren EH, Kerstjens HA: Cognitive performance in patients with COPD. Respir Med 2004; 98: 351-356.
8. Cook NR, Albert MS, Berkman LF, Blazer D, Taylor JO, Hennekens CH: Interrelationships of peak expiratory flow rate with physical and cognitive function in the elderly: MacArthur Foundation studies of aging. J Gerontol A Biol Sci Med Sci 1995; 50:M317-M323.
9. Schaub RT, Munzberg H, Borchelt M, Nieczaj R, Hillen T, Reischies FM, Schlattmann P, Geiselmann B, Steinhagen-Thiessen E: Ventilatory capacity and risk for dementia. J Gerontol A Biol Sci Med Sci 2000; 55:M677-M683.
10. Sachdev PS, Anstey KJ, Parslow RA, Wen W, Maller J, Kumar R, Christensen H, Jorm AF: Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample. Dement Geriatr Cogn Disord 2006; 21: 300-308.
11. Richards M, Strachan D, Hardy R, Kuh D, Wadsworth M: Lung function and cognitive ability in a longitudinal birth cohort study. Psychosom Med 2005; 67: 602-608. (Pubitemid 41033590)
12. Emery CF, Pedersen NL, Svartengren M, McClearn GE: Longitudinal and genetic effects in the relationship between pulmonary function and cognitive performance. J Gerontol B Psychol Sci Soc Sci 1998; 53: 311-317.
13. Albert MS, Jones K, Savage CR, Berkman L, Seeman T, Blazer D, Rowe JW: Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging 1995; 10: 578-589.
14. Chyou PH, White LR, Yano K, Sharp DS, Burchfiel CM, Chen R, Rodriguez BL, Curb JD: Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol 1996; 143: 750-756.
15. Guo X, Waern M, Sjogren K, Lissner L, Bengtsson C, Bjorkelund C, Ostling S, Gustafson D, Skoog I: Midlife respiratory function and incidence of Alzheimer's disease: A 29-year longitudinal study in women. Neurobiol Aging 2007; 28: 343-350.
16. Keys A, Aravanis C, Blackburn HW, Van Buchem FS, Buzina R, Djordjevic BD, Dontas AS, Fidanza F, Karvonen MJ, Kimura N, Lekos D, Monti M, Puddu V, Taylor HL: Epidemiological studies related to coronary heart disease: Characteristics of men aged 40-59 in seven countries. Acta Med Scand Suppl 1966; 460: 1-392.
17. Tabak C, Smit HA, Rasanen L, Fidanza F, Menotti A, Nissinen A, Feskens EJ, Heederik D, Kromhout D: Dietary factors and pulmonary function: A cross sectional study in middle aged men from three European countries. Thorax 1999; 54: 1021-1026.
18. Pelkonen M, Tukiainen H, Tervahauta M, Notkola IL, Kivela SL, Salorinne Y, Nissinen A: Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax 2000; 55: 746-750.
19. Folstein MF, Folstein SE, McHugh PR: 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
21. Juva K, Sulkava R, Erkinjuntti T, Ylikoski R, Valvanne J, Tilvis R: Usefulness of the Clinical Dementia Rating scale in screening for dementia. Int Psychogeriatr 1995; 7: 17-24.
22. Havekes LM, Deknijff P, Beisiegel U, Havinga J, Smit M, Klasen E: A rapid micromethod for apolipoprotein-e phenotyping directly in serum. J Lipid Res 1987; 28: 455-463.
23. Streppel MT, Boshuizen HC, Ocke MC, Kok FJ, Kromhout D: Mortality and life expectancy in relation to long-term cigarette, cigar and pipe smoking: The Zutphen Study. Tob Control 2007; 16: 107-113.
24. Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD, Heiss G: Lung function and incident coronary heart disease: The Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003; 158: 1171-1181. (Pubitemid 37548787)
25. Hozawa A, Billings JL, Shahar E, Ohira T, Rosamond WD, Folsom AR: Lung function and ischemic stroke incidence: The Atherosclerosis Risk in Communities Study. Chest 2006; 130: 1642-1649. (Pubitemid 46033414)
26. Gunnell D, Whitley E, Upton MN, McConnachie A, Smith GD, Watt GC: Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study. J Epidemiol Community Health 2003; 57: 141-146.
27. Ewbank DC: The APOE gene and differences in life expectancy in Europe. J Gerontol A Biol Sci Med Sci 2004; 59: 16-20.
28. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L: The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999; 282: 40-46.
29. Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ: Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: The Cardiovascular Health Study Cognition Study. Arch Neurol 2008; 65: 89-93.
30. Parekh PI, Blumenthal JA, Babyak MA, LaCaille R, Rowe S, Dancel L, Carney RM, Davis RD, Palmer S: Gas exchange and exercise capacity affect neurocognitive performance in patients with lung disease. Psychosom Med 2005; 67: 425-432.
31. Neubauer JA. Invited review: Physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol 2001; 90: 1593-1599.
32. Zauner A, Daugherty WP, Bullock MR, Warner DS: Brain oxygenation and energy metabolism. Part 1 - Biological function and pathophysiology. Neurosurgery 2002; 51: 289-301.
33. Guo X, Pantoni L, Simoni M, Gustafson D, Bengtsson C, Palmertz B, Skoog I: Midlife respiratory function related to white matter lesions and lacunar infarcts in late life: The Prospective Population Study of Women in Gothenburg, Sweden. Stroke 2006; 37: 1658-1662.
34. Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME: Positron emission tomography in evaluation of dementia: Regional brain metabolism and longterm outcome. JAMA 2001; 286: 2120-2127.
35. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J: Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004; 101: 284-289.
36. Hancox RJ, Poulton R, Greene JM, McLachlan CR, Pearce MS, Sears MR: Associations between birth weight, early childhood weight gain and adult lung function. Thorax 2009; 64: 228-232.
37. Suglia SF, Wright RO, Schwartz J, Wright RJ: Association between lung function and cognition among children in a prospective birth cohort study. Psychosom Med 2008; 70: 356-362. (Pubitemid 351543504)
38. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944